Global Over the Counter (OTC) Analgesics Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Over the Counter (OTC) Analgesics will have significant change from previous year. By the most conservative estimates of global Over the Counter (OTC) Analgesics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Over the Counter (OTC) Analgesics market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Over the Counter (OTC) Analgesics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Over the Counter (OTC) Analgesics, covering the supply chain analysis, impact assessment to the Over the Counter (OTC) Analgesics market size growth rate in several scenarios, and the measures to be undertaken by Over the Counter (OTC) Analgesics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablet
Capsule
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Sanofi SA
Johnson & Johnson
Novartis
Sun Pharma
AstraZeneca
GlaxoSmithKline PLC
Bayer AG
Reckitt Benckiser Group PLC
Boehringer Ingelheim International GmbH
Takeda Pharmaceutical Company Limited.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Over the Counter (OTC) Analgesics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Over the Counter (OTC) Analgesics market by identifying its various subsegments.
Focuses on the key global Over the Counter (OTC) Analgesics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Over the Counter (OTC) Analgesics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Over the Counter (OTC) Analgesics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Over the Counter (OTC) Analgesics?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Over the Counter (OTC) Analgesics Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Over the Counter (OTC) Analgesics Consumption 2015-2025
2.1.2 Over the Counter (OTC) Analgesics Consumption CAGR by Region
2.2 Over the Counter (OTC) Analgesics Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Other
2.3 Over the Counter (OTC) Analgesics Consumption by Type
2.3.1 Global Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
2.3.2 Global Over the Counter (OTC) Analgesics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Over the Counter (OTC) Analgesics Sale Price by Type (2015-2020)
2.4 Over the Counter (OTC) Analgesics Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Over the Counter (OTC) Analgesics Consumption by Application
2.5.1 Global Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
2.5.2 Global Over the Counter (OTC) Analgesics Value and Market Share by Type (2015-2020)
2.5.3 Global Over the Counter (OTC) Analgesics Sale Price by Type (2015-2020)
3 Global Over the Counter (OTC) Analgesics by Company
3.1 Global Over the Counter (OTC) Analgesics Sales Market Share by Company
3.1.1 Global Over the Counter (OTC) Analgesics Sales by Company (2018-2020)
3.1.2 Global Over the Counter (OTC) Analgesics Sales Market Share by Company (2018-2020)
3.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Company
3.2.1 Global Over the Counter (OTC) Analgesics Revenue by Company (2018-2020)
3.2.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Company (2018-2020)
3.3 Global Over the Counter (OTC) Analgesics Sale Price by Company
3.4 Global Over the Counter (OTC) Analgesics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Over the Counter (OTC) Analgesics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Over the Counter (OTC) Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Over the Counter (OTC) Analgesics by Regions
4.1 Over the Counter (OTC) Analgesics by Regions
4.2 Americas Over the Counter (OTC) Analgesics Consumption Growth
4.3 APAC Over the Counter (OTC) Analgesics Consumption Growth
4.4 Europe Over the Counter (OTC) Analgesics Consumption Growth
4.5 Middle East & Africa Over the Counter (OTC) Analgesics Consumption Growth
5 Americas
5.1 Americas Over the Counter (OTC) Analgesics Consumption by Countries
5.1.1 Americas Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020)
5.1.2 Americas Over the Counter (OTC) Analgesics Value by Countries (2015-2020)
5.2 Americas Over the Counter (OTC) Analgesics Consumption by Type
5.3 Americas Over the Counter (OTC) Analgesics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Over the Counter (OTC) Analgesics Consumption by Regions
6.1.1 APAC Over the Counter (OTC) Analgesics Consumption by Regions (2015-2020)
6.1.2 APAC Over the Counter (OTC) Analgesics Value by Regions (2015-2020)
6.2 APAC Over the Counter (OTC) Analgesics Consumption by Type
6.3 APAC Over the Counter (OTC) Analgesics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Over the Counter (OTC) Analgesics by Countries
7.1.1 Europe Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020)
7.1.2 Europe Over the Counter (OTC) Analgesics Value by Countries (2015-2020)
7.2 Europe Over the Counter (OTC) Analgesics Consumption by Type
7.3 Europe Over the Counter (OTC) Analgesics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Over the Counter (OTC) Analgesics by Countries
8.1.1 Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Over the Counter (OTC) Analgesics Value by Countries (2015-2020)
8.2 Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Type
8.3 Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Over the Counter (OTC) Analgesics Distributors
10.3 Over the Counter (OTC) Analgesics Customer
11 Global Over the Counter (OTC) Analgesics Market Forecast
11.1 Global Over the Counter (OTC) Analgesics Consumption Forecast (2021-2025)
11.2 Global Over the Counter (OTC) Analgesics Forecast by Regions
11.2.1 Global Over the Counter (OTC) Analgesics Forecast by Regions (2021-2025)
11.2.2 Global Over the Counter (OTC) Analgesics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Over the Counter (OTC) Analgesics Forecast by Type
11.8 Global Over the Counter (OTC) Analgesics Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Over the Counter (OTC) Analgesics Product Offered
12.1.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Sanofi SA
12.2.1 Company Information
12.2.2 Over the Counter (OTC) Analgesics Product Offered
12.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sanofi SA Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Over the Counter (OTC) Analgesics Product Offered
12.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Novartis
12.4.1 Company Information
12.4.2 Over the Counter (OTC) Analgesics Product Offered
12.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novartis Latest Developments
12.5 Sun Pharma
12.5.1 Company Information
12.5.2 Over the Counter (OTC) Analgesics Product Offered
12.5.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sun Pharma Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Over the Counter (OTC) Analgesics Product Offered
12.6.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 GlaxoSmithKline PLC
12.7.1 Company Information
12.7.2 Over the Counter (OTC) Analgesics Product Offered
12.7.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 GlaxoSmithKline PLC Latest Developments
12.8 Bayer AG
12.8.1 Company Information
12.8.2 Over the Counter (OTC) Analgesics Product Offered
12.8.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Bayer AG Latest Developments
12.9 Reckitt Benckiser Group PLC
12.9.1 Company Information
12.9.2 Over the Counter (OTC) Analgesics Product Offered
12.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Reckitt Benckiser Group PLC Latest Developments
12.10 Boehringer Ingelheim International GmbH
12.10.1 Company Information
12.10.2 Over the Counter (OTC) Analgesics Product Offered
12.10.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Boehringer Ingelheim International GmbH Latest Developments
12.11 Takeda Pharmaceutical Company Limited.
12.11.1 Company Information
12.11.2 Over the Counter (OTC) Analgesics Product Offered
12.11.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Takeda Pharmaceutical Company Limited. Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Over the Counter (OTC) Analgesics Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Over the Counter (OTC) Analgesics Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Over the Counter (OTC) Analgesics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Tablet
Table 7. Major Players of Capsule
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Table 11. Global Over the Counter (OTC) Analgesics Revenue by Type (2015-2020) ($ million)
Table 12. Global Over the Counter (OTC) Analgesics Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Over the Counter (OTC) Analgesics Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Table 16. Global Over the Counter (OTC) Analgesics Value by Application (2015-2020)
Table 17. Global Over the Counter (OTC) Analgesics Value Market Share by Application (2015-2020)
Table 18. Global Over the Counter (OTC) Analgesics Sale Price by Application (2015-2020)
Table 19. Global Over the Counter (OTC) Analgesics Sales by Company (2017-2019) (K Units)
Table 20. Global Over the Counter (OTC) Analgesics Sales Market Share by Company (2017-2019)
Table 21. Global Over the Counter (OTC) Analgesics Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Over the Counter (OTC) Analgesics Revenue Market Share by Company (2017-2019)
Table 23. Global Over the Counter (OTC) Analgesics Sale Price by Company (2017-2019)
Table 24. Global Over the Counter (OTC) Analgesics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Over the Counter (OTC) Analgesics Products Offered
Table 26. Over the Counter (OTC) Analgesics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Over the Counter (OTC) Analgesics Consumption by Regions 2015-2020 (K Units)
Table 28. Global Over the Counter (OTC) Analgesics Consumption Market Share by Regions 2015-2020
Table 29. Global Over the Counter (OTC) Analgesics Value by Regions 2015-2020 ($ Millions)
Table 30. Global Over the Counter (OTC) Analgesics Value Market Share by Regions 2015-2020
Table 31. Americas Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Countries (2015-2020)
Table 33. Americas Over the Counter (OTC) Analgesics Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Over the Counter (OTC) Analgesics Value Market Share by Countries (2015-2020)
Table 35. Americas Over the Counter (OTC) Analgesics Consumption by Type (2015-2020) (K Units)
Table 36. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Table 37. Americas Over the Counter (OTC) Analgesics Consumption by Application (2015-2020) (K Units)
Table 38. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Table 39. APAC Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Countries (2015-2020)
Table 41. APAC Over the Counter (OTC) Analgesics Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Over the Counter (OTC) Analgesics Value Market Share by Regions (2015-2020)
Table 43. APAC Over the Counter (OTC) Analgesics Consumption by Type (2015-2020) (K Units)
Table 44. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Table 45. APAC Over the Counter (OTC) Analgesics Consumption by Application (2015-2020) (K Units)
Table 46. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Table 47. Europe Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Countries (2015-2020)
Table 49. Europe Over the Counter (OTC) Analgesics Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Over the Counter (OTC) Analgesics Value Market Share by Countries (2015-2020)
Table 51. Europe Over the Counter (OTC) Analgesics Consumption by Type (2015-2020) (K Units)
Table 52. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Table 53. Europe Over the Counter (OTC) Analgesics Consumption by Application (2015-2020) (K Units)
Table 54. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Over the Counter (OTC) Analgesics Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Over the Counter (OTC) Analgesics Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Over the Counter (OTC) Analgesics Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Table 63. Over the Counter (OTC) Analgesics Distributors List
Table 64. Over the Counter (OTC) Analgesics Customer List
Table 65. Global Over the Counter (OTC) Analgesics Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Over the Counter (OTC) Analgesics Consumption Market Forecast by Regions
Table 67. Global Over the Counter (OTC) Analgesics Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Over the Counter (OTC) Analgesics Value Market Share Forecast by Regions
Table 69. Global Over the Counter (OTC) Analgesics Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Over the Counter (OTC) Analgesics Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Over the Counter (OTC) Analgesics Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Over the Counter (OTC) Analgesics Value Market Share Forecast by Type (2021-2025)
Table 73. Global Over the Counter (OTC) Analgesics Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Over the Counter (OTC) Analgesics Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Over the Counter (OTC) Analgesics Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Over the Counter (OTC) Analgesics Value Market Share Forecast by Application (2021-2025)
Table 77. Pfizer Product Offered
Table 78. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. Pfizer Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 82. Sanofi SA Product Offered
Table 83. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 84. Sanofi SA Main Business
Table 85. Sanofi SA Latest Developments
Table 86. Sanofi SA Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Product Offered
Table 88. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Product Offered
Table 93. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Novartis Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 97. Sun Pharma Product Offered
Table 98. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 99. Sun Pharma Main Business
Table 100. Sun Pharma Latest Developments
Table 101. Sun Pharma Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca Product Offered
Table 103. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. AstraZeneca Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 107. GlaxoSmithKline PLC Product Offered
Table 108. GlaxoSmithKline PLC Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline PLC Main Business
Table 110. GlaxoSmithKline PLC Latest Developments
Table 111. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Bayer AG Product Offered
Table 113. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Bayer AG Main Business
Table 115. Bayer AG Latest Developments
Table 116. Bayer AG Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 117. Reckitt Benckiser Group PLC Product Offered
Table 118. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 119. Reckitt Benckiser Group PLC Main Business
Table 120. Reckitt Benckiser Group PLC Latest Developments
Table 121. Reckitt Benckiser Group PLC Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 122. Boehringer Ingelheim International GmbH Product Offered
Table 123. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 124. Boehringer Ingelheim International GmbH Main Business
Table 125. Boehringer Ingelheim International GmbH Latest Developments
Table 126. Boehringer Ingelheim International GmbH Basic Information, Company Total Revenue (in $ million), Over the Counter (OTC) Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 127. Takeda Pharmaceutical Company Limited. Product Offered
Table 128. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 129. Takeda Pharmaceutical Company Limited. Main Business
Table 130. Takeda Pharmaceutical Company Limited. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Pharmaceutical Company Limited. Latest Developments
List of Figures
Figure 1. Picture of Over the Counter (OTC) Analgesics
Figure 2. Over the Counter (OTC) Analgesics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Over the Counter (OTC) Analgesics Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Over the Counter (OTC) Analgesics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablet
Figure 7. Product Picture of Capsule
Figure 8. Product Picture of Other
Figure 9. Global Over the Counter (OTC) Analgesics Consumption Market Share by Type (2015-2020)
Figure 10. Global Over the Counter (OTC) Analgesics Value Market Share by Type (2015-2020)
Figure 11. Over the Counter (OTC) Analgesics Consumed in Retail Pharmacies
Figure 12. Global Over the Counter (OTC) Analgesics Market: Retail Pharmacies (2015-2020) (K Units)
Figure 13. Global Over the Counter (OTC) Analgesics Market: Retail Pharmacies (2015-2020) ($ Millions)
Figure 14. Over the Counter (OTC) Analgesics Consumed in Hospital Pharmacies
Figure 15. Global Over the Counter (OTC) Analgesics Market: Hospital Pharmacies (2015-2020) (K Units)
Figure 16. Global Over the Counter (OTC) Analgesics Market: Hospital Pharmacies (2015-2020) ($ Millions)
Figure 17. Over the Counter (OTC) Analgesics Consumed in Online Pharmacies
Figure 18. Global Over the Counter (OTC) Analgesics Market: Online Pharmacies (2015-2020) (K Units)
Figure 19. Global Over the Counter (OTC) Analgesics Market: Online Pharmacies (2015-2020) ($ Millions)
Figure 20. Global Over the Counter (OTC) Analgesics Consumption Market Share by Application (2015-2020)
Figure 21. Global Over the Counter (OTC) Analgesics Value Market Share by Application (2015-2020)
Figure 22. Global Over the Counter (OTC) Analgesics Sales Market Share by Company in 2017
Figure 23. Global Over the Counter (OTC) Analgesics Sales Market Share by Company in 2019
Figure 24. Global Over the Counter (OTC) Analgesics Revenue Market Share by Company in 2017
Figure 25. Global Over the Counter (OTC) Analgesics Revenue Market Share by Company in 2019
Figure 26. Global Over the Counter (OTC) Analgesics Sale Price by Company in 2019
Figure 27. Global Over the Counter (OTC) Analgesics Consumption Market Share by Regions 2015-2020
Figure 28. Global Over the Counter (OTC) Analgesics Value Market Share by Regions 2015-2020
Figure 29. Americas Over the Counter (OTC) Analgesics Consumption 2015-2020 (K Units)
Figure 30. Americas Over the Counter (OTC) Analgesics Value 2015-2020 ($ Millions)
Figure 31. APAC Over the Counter (OTC) Analgesics Consumption 2015-2020 (K Units)
Figure 32. APAC Over the Counter (OTC) Analgesics Value 2015-2020 ($ Millions)
Figure 33. Europe Over the Counter (OTC) Analgesics Consumption 2015-2020 (K Units)
Figure 34. Europe Over the Counter (OTC) Analgesics Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Over the Counter (OTC) Analgesics Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Over the Counter (OTC) Analgesics Value 2015-2020 ($ Millions)
Figure 37. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Countries in 2019
Figure 38. Americas Over the Counter (OTC) Analgesics Value Market Share by Countries in 2019
Figure 39. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Type in 2019
Figure 40. Americas Over the Counter (OTC) Analgesics Consumption Market Share by Application in 2019
Figure 41. United States Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 42. United States Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Countries in 2019
Figure 48. APAC Over the Counter (OTC) Analgesics Value Market Share by Regions in 2019
Figure 49. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Type in 2019
Figure 50. APAC Over the Counter (OTC) Analgesics Consumption Market Share by Application in 2019
Figure 51. China Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 52. China Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 59. India Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 60. India Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Countries in 2019
Figure 64. Europe Over the Counter (OTC) Analgesics Value Market Share by Countries in 2019
Figure 65. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Type in 2019
Figure 66. Europe Over the Counter (OTC) Analgesics Consumption Market Share by Application in 2019
Figure 67. Germany Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 69. France Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 70. France Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 71. UK Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 72. UK Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Over the Counter (OTC) Analgesics Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Over the Counter (OTC) Analgesics Consumption Market Share by Application in 2019
Figure 81. Egypt Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Over the Counter (OTC) Analgesics Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Over the Counter (OTC) Analgesics Value Growth 2015-2020 ($ Millions)
Figure 91. Global Over the Counter (OTC) Analgesics Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Over the Counter (OTC) Analgesics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 94. Americas Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 95. APAC Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 96. APAC Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 97. Europe Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 98. Europe Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 101. United States Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 102. United States Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 103. Canada Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 104. Canada Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 105. Mexico Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 106. Mexico Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 107. Brazil Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 108. Brazil Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 109. China Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 110. China Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 111. Japan Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 112. Japan Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 113. Korea Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 114. Korea Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 117. India Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 118. India Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 119. Australia Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 120. Australia Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 121. Germany Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 122. Germany Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 123. France Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 124. France Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 125. UK Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 126. UK Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 127. Italy Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 128. Italy Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 129. Russia Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 130. Russia Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 131. Spain Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 132. Spain Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 133. Egypt Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 134. Egypt Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 135. South Africa Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 136. South Africa Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 137. Israel Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 138. Israel Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 139. Turkey Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 140. Turkey Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Over the Counter (OTC) Analgesics Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Over the Counter (OTC) Analgesics Value 2021-2025 ($ Millions)
Figure 143. Pfizer Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 144. Sanofi SA Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 145. Johnson & Johnson Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 146. Novartis Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 147. Sun Pharma Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 148. AstraZeneca Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 149. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 150. Bayer AG Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 151. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 152. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Market Share (2018-2020)
Figure 153. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets